RADIATION TREATMENT OF UNRESECTABLE LARYNGEAL CANCER
https://doi.org/10.21294/1814-4861-2016-15-3-72-77
Abstract
The treatment outcomes of unresectable laryngeal cancer have been presented. The techniques of radiation therapy (RT) alone and concurrent chemoradiotherapy (CRT), as well as the effect of changes in the fractionation regimens on the treatment outcome have been analyzed. No differences in overall survival (OS) and locoregional control (LC) between the RT and CRT techniques were found (p<0.8). There is a trend toward improvement in OS (p<0.1) and LC (p<0.05) in laryngeal cancer patients treated with hyperftactionated radiation therapy.

About the Authors
K. B. GordonRussian Federation
Researcher, Radiologist, Department of Distant Beam Radiation Therapy
I. A. Gulidov
Russian Federation
MD, DSc, Professor, Head of the Department of Distant Beam Radiation Therapy
V. A. Rozhnov
Russian Federation
MD, DSc, Leading Researcher, Department of Radiotherapy and Surgery for Diseases of the Upper Respiratory Tract
V. G. Andreev
Russian Federation
MD, DSc, Professor, Leading Researcher, Head of the Department of Radiotherapy and Surgery for Diseases of the Upper Respiratory Tract
N. I. Podlesnykh
Russian Federation
Radiologist, Department of Distant Beam Radiation Therapy
V. A. Pankratov
Russian Federation
MD, DSc, Leading Researcher, Department of Radiotherapy and Surgery for Diseases of the Upper Respiratory Tract
References
1. Andreev V.G., Mardynskij Yu.S. Radiotherapy and combined treatment of laryngeal cancer. M., 1998. 116 p. [in Russian]
2. Gogolon D.V., Mardynskij Yu.S., Gulidov I.A., Results of hyperfractionated accelerated irradiation in the treatment of non-small cell lung cancer // The Abstr. Book of «Nevskij radiological forum». SPb., 2011. P. 55–56. [in Russian]
3. Gumenetskaya Yu.V. Unconventional fractionation external beam radiation therapy for treatment patients with muscle-invasive bladder cancer (review of the literature) // Sibirskij onkologicheskij zhurnal. 2012. № 4. P. 63–69. [in Russian]
4. Kaprin A.D., Starinskij V.V., Petrova G.V. Malignancies in Russia in 2012 (morbidity and mortality). М., 2014. 250 p. [in Russian]
5. Muhamedov M.R., Cheremisina O.V., Choynzonov E.L., Kulbakin D.E., Balatskaya L.N., Vasiliev N.V., Gunther V.E. The modern view on complex approach when diagnostic, treating and aftercaring in larynx cancer patients // Rossijskaja otorinolaringologija. 2012. № 3. P. 78–84. [in Russian]
6. Paches A.I. Head and neck tumors. М., 2000. P. 346–379. [in Russian]
7. Rozhnov V.A., Andreev V.G., Gulidov I.A., Pankratov V.A., Baryshev V.V., Buyakova M.E., Vdovina S.N. Palliative treatment of patients with inoperable recurrent laryngeal cancer // Sibirskij onkologicheskij zhurnal. 2008. № 3. P. 29–33. [in Russian]
8. Adelstein D., Li Y., Adams G.L., Wagner H.Jr., Kish J.A., Ensley J.F., Schuller D.E., Forastiere A.A. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer // J. Clin. Oncol. 2003. Vol. 21 (1). P. 92–98.
9. Denaro N., Russi E.G., Merlano M.C. Strategies for non-resectable head and neck cancer // Curr. Treat. Options Oncol. 2013. Vol. 14 (4). P. 492–504. doi: 10.1007/s11864-013-0260-6.
10. Forastiere A.A., Zhang Q., Weber R.S., Maor M.H., Goepfert H.,Pajak T.F., Morrison W., Glisson B., Trotti A., Ridge J.A., Thorstad W., Wagner H., Ensley J.F., Cooper J.S. Long-term results of RTOG 91–11: a comparison of three non surgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer // J. Clin. Oncol. 2013. Vol. 31 (7). P. 845–852. doi: 10.1200/JCO.2012.43.6097.
11. Fu K.K., Pajak T.F., Trotti A., Jones C.U., Spencer S.A., Phillips T.L., Garden A.S., Ridge J.A., Cooper J.S., Ang K.K. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 // Int. J. Radiat. Oncol. Biol. Phys. 2000. Vol. 48 (1). P. 7–16.
12. Mouw K.W., Haraf D.J., Stenson K.M., Cohen E.E., Xi X., Witt M.E., List M., Blair E.A., Vokes E.E., Salama J.K. Factors associated with longterm speech and swallowing outcomes after chemoradiotherapy for locally advanced head and neck cancer // Arch. Otolaryngol. Head Neck Surg. 2010. Vol. 136 (12). P. 1226–1234. doi: 10.1001/archoto.2010.218.
13. Rosen F. Unresectable, Locoregionally Advanced Head and Neck Cancer Head and Neck Cancer // Cancer Treat. Res. 2003. Vol. 114. P. 249–273.
14. Russi E., Corvo R., Merlotti A., Alterio D., Franco P., Pergolizzi S., De Sanctis V., Ruo Redda M.G., Ricardi U., Paiar F., Bonomo P., Merlano M.C., Zurlo V., Chiesa F., Sanguineti G., Bernier J. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology // Cancer Treat. Rev. 2012. Vol. 38 (8). P. 1033–1049. doi: 10.1016/j.ctrv.2012.04.002.
15. Russo G., Haddad R., Posner M., Machtay M. Radiation treatment breaks and ulcerative mucositis in head and neck cancer // Oncologist. 2008. Vol. 13 (8). P. 886–898. doi: 10.1634/theoncologist.2008-0024.
16. Volling P., Staar S., Eckel H., Stennert E., Achterrath W., Muller R. Accelerated split-course radiation and simultaneous chemotherapy in patients with unresectable head and neck-cancer // Int. J. Oncol. 1994. Vol. 4 (1). P. 143–149.
17. Yousem D.M., Gad K., Tufano R.P. Resectability issues with head and neck cancer // AJNR. Am. J. Neuroradiol. 2006. Vol. 27 (10). P. 2024–2036.
18.
Review
For citations:
Gordon K.B., Gulidov I.A., Rozhnov V.A., Andreev V.G., Podlesnykh N.I., Pankratov V.A. RADIATION TREATMENT OF UNRESECTABLE LARYNGEAL CANCER. Siberian journal of oncology. 2016;15(3):72-77. (In Russ.) https://doi.org/10.21294/1814-4861-2016-15-3-72-77